We are live on ! Find out more
VINC

Vincerx Pharma, Inc. Common Stock

Delisted

VINC was delisted on the 22nd of April, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$2.02M -$297K -17,663 -17%
SRC
2
Sage Rhino Capital
California
$2.01M
LFCM
3
Long Focus Capital Management
Puerto Rico
$1.3M
Bank of America
4
Bank of America
North Carolina
$1.28M -$311K -18,502 -25%
RSCM
5
Rock Springs Capital Management
Maryland
$1.05M
Vanguard Group
6
Vanguard Group
Pennsylvania
$606K
KCM
7
Kingdon Capital Management
New York
$454K
RCMNY
8
Rubric Capital Management (New York)
New York
$418K
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$407K
ECM
10
ExodusPoint Capital Management
New York
$382K -$55K -3,270 -17%
TC
11
Tejara Capital
United Kingdom
$275K
Citadel Advisors
12
Citadel Advisors
Florida
$233K +$24K +1,427 +17%
Renaissance Technologies
13
Renaissance Technologies
New York
$208K +$36.2K +2,156 +32%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$182K
Walleye Capital
15
Walleye Capital
New York
$136K
SSA
16
Schonfeld Strategic Advisors
New York
$135K
SCM
17
Sio Capital Management
New York
$120K
BlackRock
18
BlackRock
New York
$75.8K
MG
19
Marex Group
$58.3K +$41.5K +2,470 New
State Street
20
State Street
Massachusetts
$50.9K
Acadian Asset Management
21
Acadian Asset Management
Massachusetts
$48K
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$48K
Millennium Management
23
Millennium Management
New York
$40.7K -$2.19K -130 -7%
Northern Trust
24
Northern Trust
Illinois
$30.2K
Morgan Stanley
25
Morgan Stanley
New York
$21K -$5.93K -353 -28%